| 000 | 01517nam a2200373 a 4500 | ||
|---|---|---|---|
| 001 | 0000072555 | ||
| 005 | 20171002053614.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 950316s1995 dcu sb f000 0 eng | ||
| 010 | _z 95068327 | ||
| 020 | _z0309052793 | ||
| 035 | _a(CaPaEBR)ebr10056943 | ||
| 035 | _a(OCoLC)228064162 | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 050 | 1 | 4 |
_aRC848.H44 _bR48 1995eb |
| 082 | 0 | 4 |
_a616.3/623061 _220 |
| 245 | 0 | 0 |
_aReview of the Fialuridine (FIAU) clinical trials _h[electronic resource] / _cFrederick J. Manning and Morton Swartz, editors. |
| 260 |
_aWashington, DC : _bNational Academy Press, _c1995. |
||
| 300 | _aix, 269 p. | ||
| 500 | _a"Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Division of Health Sciences Policy, Institute of Medicine". | ||
| 504 | _aIncludes bibliographical references (p. 165-177). | ||
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 |
_aHepatitis B _xChemotherapy _xEvaluation. |
|
| 650 | 0 |
_aFialuridine _xTesting. |
|
| 650 | 0 |
_aFiacitabine _xTesting. |
|
| 650 | 0 |
_aClinical trials _xSafety measures. |
|
| 655 | 7 |
_aElectronic books. _2local |
|
| 700 | 1 | _aManning, Frederick J. | |
| 700 | 1 | _aSwartz, Morton N. | |
| 710 | 2 | _aebrary, Inc. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10056943 _zAn electronic book accessible through the World Wide Web; click to view |
| 908 | _a170314 | ||
| 942 | 0 | 0 | _cEB |
| 999 |
_c61713 _d61713 |
||